Publication Name	World Journal of Clinical Cases
Manuscript ID	84199
Country	China

Received	2023-03-02 14:00
Peer-Review Started	2023-03-02 14:02
To Make the First Decision
Return for Revision	2023-06-12 02:49
Revised	2023-07-07 03:22
Second Decision	2023-07-17 02:48
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-07-17 07:11
Articles in Press	2023-07-17 07:11
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-07-27 11:29
Publish the Manuscript Online	2023-08-03 10:22

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Urology & Nephrology
Manuscript Type	Case Report
Article Title	Anti-phospholipase A2 receptor-associated membranous nephropathy with human immunodeficiency virus infection treated with telitacicept: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Jin-Ling Wang, Yan-Ling Sun, Zhe Kang, Sheng-Kun Zhang, Chun-Xin Yu, Wan Zhang, Hong-Li Lin and Hua Xie
ORCID	Author(s) ORCID Number Hong-Li Lin http://orcid.org/0000-0002-6584-9561 Hua Xie http://orcid.org/0000-0003-4971-5333
Funding Agency and Grant Number
Corresponding Author	Hong-Li Lin, PhD, Chief Physician, Department of Nephrology, The First Affiliated Hospital of Dalian Medical University, No. 222 Zhongshan Road, Dalian 116000, Liaoning Province, China. linhongli1216@163.com
Key Words	Membranous nephropathy; PLA2R; Human immunodeficiency virus; Proteinuria; Telitacicept; Case report
Core Tip	The clinical management of anti-phospholipase A2 receptor-associated membranous nephropathy concurrent with human immunodeficiency virus infection presents significant challenges, primarily due to potential unregulated immune responses. In this report, we demonstrated that a weekly subcutaneous injection of telitacicept (160 mg) could ameliorate the 24-h urinary protein levels and enhance serum albumin concentrations, with no discernible impact on T cell counts, showcasing its safety profile.
Publish Date	2023-08-03 10:22
Citation	Wang JL, Sun YL, Kang Z, Zhang SK, Yu CX, Zhang W, Lin HL, Xie H. Anti-phospholipase A2 receptor-associated membranous nephropathy with human immunodeficiency virus infection treated with telitacicept: A case report. World J Clin Cases 2023; 5309-5315
URL	https://www.wjgnet.com/2307-8960/full/v11/i22/5309.htm
DOI	https://dx.doi.org/10.12998/wjcc.v11.i22.5309

Full Article (PDF)	WJCC-11-5309-with-cover.pdf
Full Article (Word)	WJCC-11-5309.docx
CARE Checklist–2016	84199-CARE-Checklist–2016-revision.pdf
Manuscript File	84199_Auto_Edited-LJH-JLW.docx
Answering Reviewers	84199-Answering reviewers.pdf
Audio Core Tip	84199-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	84199-Conflict-of-interest statement.pdf
Copyright License Agreement	84199-Copyright license agreement.pdf
Signed Consent for Treatment Form(s) or Document(s)	84199-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	84199-Language certificate.pdf
Peer-review Report	84199-Peer-review(s).pdf
Scientific Misconduct Check	84199-Bing-Liu JH-2.png
Scientific Misconduct Check	84199-CrossCheck.png
Scientific Editor Work List	84199-Scientific editor work list.pdf